Primary |
Renal Transplant |
20.8% |
Product Used For Unknown Indication |
15.8% |
Prophylaxis Against Transplant Rejection |
13.8% |
Drug Use For Unknown Indication |
12.2% |
Liver Transplant |
4.8% |
Systemic Lupus Erythematosus |
4.2% |
Prophylaxis Against Graft Versus Host Disease |
4.1% |
Hypertension |
3.7% |
Immunosuppression |
3.2% |
Transplant Rejection |
2.1% |
Heart Transplant |
2.1% |
Myasthenia Gravis |
1.9% |
Graft Versus Host Disease |
1.8% |
Prophylaxis |
1.8% |
Lupus Nephritis |
1.6% |
Infection Prophylaxis |
1.5% |
Nephrotic Syndrome |
1.4% |
Antifungal Prophylaxis |
1.2% |
Transplant |
1.1% |
Lung Transplant |
0.8% |
|
Death |
35.7% |
Transplant Rejection |
17.5% |
Vomiting |
5.0% |
White Blood Cell Count Decreased |
4.3% |
Kidney Transplant Rejection |
3.4% |
Cerebrovascular Accident |
3.2% |
Renal Failure |
3.2% |
Disease Progression |
2.9% |
Sepsis |
2.8% |
Thrombotic Microangiopathy |
2.7% |
Renal Impairment |
2.6% |
Pneumonia |
2.5% |
Weight Decreased |
2.2% |
Systemic Lupus Erythematosus |
2.1% |
Respiratory Failure |
1.8% |
Urinary Tract Infection |
1.7% |
Aplasia Pure Red Cell |
1.6% |
Diarrhoea |
1.6% |
Focal Segmental Glomerulosclerosis |
1.6% |
Myocardial Infarction |
1.5% |
|
Secondary |
Renal Transplant |
34.0% |
Prophylaxis Against Transplant Rejection |
11.5% |
Drug Use For Unknown Indication |
9.7% |
Product Used For Unknown Indication |
6.5% |
Hypertension |
5.2% |
Prophylaxis |
5.2% |
Heart Transplant |
4.8% |
Immunosuppression |
4.2% |
Liver Transplant |
3.4% |
Systemic Lupus Erythematosus |
2.7% |
Lung Transplant |
2.5% |
Prophylaxis Against Graft Versus Host Disease |
1.8% |
Transplant Rejection |
1.4% |
Immunosuppressant Drug Therapy |
1.3% |
Cytomegalovirus Infection |
1.2% |
Infection Prophylaxis |
1.1% |
Diabetes Mellitus |
1.0% |
Behcet's Syndrome |
0.9% |
Bone Marrow Transplant |
0.9% |
Lupus Nephritis |
0.8% |
|
Vomiting |
11.1% |
White Blood Cell Count Decreased |
10.4% |
Urinary Tract Infection |
6.9% |
Pyrexia |
6.7% |
Renal Impairment |
5.8% |
Sepsis |
5.5% |
Neutropenia |
5.1% |
Renal Failure |
5.1% |
Transplant Rejection |
5.1% |
Thrombotic Microangiopathy |
4.8% |
Weight Decreased |
4.5% |
White Blood Cell Count Increased |
4.3% |
Thrombocytopenia |
3.7% |
Pneumonia |
3.5% |
Septic Shock |
3.3% |
Cytomegalovirus Infection |
3.0% |
Viral Infection |
3.0% |
Osteoporosis |
2.8% |
Diarrhoea |
2.7% |
Renal Failure Acute |
2.6% |
|
Concomitant |
Product Used For Unknown Indication |
29.0% |
Renal Transplant |
15.4% |
Drug Use For Unknown Indication |
12.3% |
Prophylaxis Against Transplant Rejection |
7.5% |
Hypertension |
4.9% |
Immunosuppression |
4.1% |
Nuclear Magnetic Resonance Imaging |
3.3% |
Prophylaxis |
3.3% |
Liver Transplant |
3.0% |
Heart Transplant |
2.9% |
Pain |
2.7% |
Diabetes Mellitus |
1.6% |
Systemic Lupus Erythematosus |
1.6% |
Angiogram |
1.5% |
Lung Transplant |
1.5% |
Renal Failure Chronic |
1.3% |
Depression |
1.1% |
Pulmonary Arterial Hypertension |
1.0% |
Immunosuppressant Drug Therapy |
1.0% |
Anaemia |
1.0% |
|
Vomiting |
12.2% |
Death |
8.7% |
Pyrexia |
6.5% |
Weight Decreased |
6.2% |
Renal Failure Acute |
5.3% |
Transplant Rejection |
5.3% |
Therapeutic Response Decreased |
5.1% |
Kidney Transplant Rejection |
4.9% |
Thrombocytopenia |
4.9% |
Renal Failure |
4.7% |
White Blood Cell Count Decreased |
4.5% |
Pregnancy |
4.3% |
Sepsis |
4.1% |
Pneumonia |
4.0% |
Renal Impairment |
4.0% |
Drug Ineffective |
3.3% |
Urinary Tract Infection |
3.3% |
Skin Tightness |
2.9% |
Thrombotic Microangiopathy |
2.9% |
Weight Increased |
2.9% |
|
Interacting |
Drug Use For Unknown Indication |
25.4% |
Prophylaxis Against Transplant Rejection |
10.7% |
Renal Transplant |
8.5% |
Pyrexia |
7.9% |
Hypertension |
7.3% |
Immunosuppressant Drug Therapy |
6.8% |
Immunosuppression |
6.8% |
Bone Marrow Conditioning Regimen |
3.4% |
Anxiety |
2.8% |
Depression |
2.8% |
Lung Transplant |
2.8% |
Dyspepsia |
2.3% |
Gastric Disorder |
2.3% |
Infection Prophylaxis |
1.7% |
Liver Transplant |
1.7% |
Prostate Cancer |
1.7% |
Renal Lymphocele |
1.7% |
Epstein-barr Virus Infection |
1.1% |
Gastritis |
1.1% |
Gout |
1.1% |
|
Drug Interaction |
14.3% |
Graft Versus Host Disease |
14.3% |
Wrong Technique In Drug Usage Process |
11.9% |
Fatigue |
7.1% |
White Blood Cell Count Decreased |
7.1% |
Sjogren's Syndrome |
4.8% |
Somnolence |
4.8% |
Staphylococcal Infection |
4.8% |
Tremor |
4.8% |
Delirium |
2.4% |
Haemoglobin Decreased |
2.4% |
Liver Disorder |
2.4% |
Pulmonary Tuberculosis |
2.4% |
Renal Failure Acute |
2.4% |
Renal Impairment |
2.4% |
Restlessness |
2.4% |
Splenomegaly |
2.4% |
Transplant Rejection |
2.4% |
Ventricular Extrasystoles |
2.4% |
Viral Infection |
2.4% |
|